Mereo BioPharma Group plc Cash And Cash Equivalents At Carrying Value

Quick Answer

Mereo BioPharma Group plc reported Cash And Cash Equivalents At Carrying Value of $40.99 million for the year ending 2025.

  • Mereo BioPharma Group plc showed a decrease of -41.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Mereo BioPharma Group plc's annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Mereo BioPharma Group plc's Cash And Cash Equivalents At Carrying Value has declined by 39.9%.
  • Historical annual values: Fiscal year 2025: $40.99 million | Fiscal year 2024: $69.80 million | Fiscal year 2023: $57.42 million | Fiscal year 2022: $68.18 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: